Related by context. All words. (Click for frequent words.) 83 cardiovascular hospitalizations 75 myocardial infarction stroke 75 reinfarction 74 nonfatal myocardial infarction 73 nonfatal MI 73 nonfatal stroke 72 HF hospitalization 71 recurrent myocardial infarction 71 Erythropoietic therapies may 69 fatal myocardial infarction 69 myocardial infarction MI 69 cerebrovascular events 68 symptomatic VTE 68 recurrent ischemia 68 recurrent VTE 68 repeat revascularization 68 NYHA Class II 67 systemic embolism 67 thrombotic events 67 upper gastrointestinal bleeding 66 ipsilateral stroke 66 atherothrombotic disease 66 morphometric vertebral fractures 66 CHD CVD 66 binary restenosis 66 composite endpoint 66 venous thromboembolic events 66 thromboembolic 66 cardiovascular morbidity 65 thromboembolic events 65 cardiac dysfunction 65 refractory ischemia 65 XIENCE V PROMUS Stent 65 resuscitated cardiac arrest 65 definite stent thrombosis 65 nonfatal myocardial infarction MI 65 cardiovascular mortality 65 thromboembolism 65 atherothrombotic events 65 macrovascular events 65 non valvular atrial 65 hemorrhagic complications 65 TAXUS Express Stent 65 recurrent stroke 64 thromboembolic complications 64 CVD mortality 64 ischemic cardiomyopathy 64 dronedarone 64 eplerenone 64 severe exacerbations 64 rosuvastatin #mg 64 rebleeding 64 LV dysfunction 64 arterial thromboembolic events 64 Myocardial infarction 64 recurrent venous thromboembolism 64 ATACAND 63 #.#/#.# mmHg [001] 63 glycated hemoglobin levels 63 pulmonary embolism PE 63 infarct size 63 LOVENOX 63 de ath 63 antiarrhythmic drug 63 periprocedural 63 cardiogenic shock 63 cirrhosis liver failure 63 myocardial infarctions 63 postoperative AF 63 β blockers 63 macrovascular 63 ventricular tachyarrhythmia 62 recurrent DVT 62 ADHF 62 myocardial infarction 62 myocardial infarction ventricular fibrillation 62 ischemia driven 62 MACCE 62 ivabradine 62 TAXUS p value 62 patients undergoing CABG 62 renal flares 62 acute myocardial infarction AMI 62 tumor lysis syndrome 62 arterial thrombosis 62 VT VF 62 rehospitalization 62 nonfatal pulmonary embolism 62 fatal IHD 62 unstable angina pectoris 62 pCR 62 preserved ejection fraction 62 perioperative mortality 62 coronary revascularization 62 acute coronary syndromes ACS 62 Events MACE 62 nonfasting triglyceride levels 62 elevated triglyceride levels 61 serum phosphorous 61 antithrombotic therapy 61 artery reclogging 61 polyp recurrence 61 beta blocker therapy 61 carotid stenosis 61 STRIDE PD 61 decompensated heart failure 61 ARIXTRA 61 PSADT 61 defibrillator CRT D 61 salmeterol HFA MDI 61 NATRECOR ® 61 hyperphenylalaninemia HPA due 61 acutely decompensated congestive heart 61 nondiabetic patients 61 azacitidine 61 microvascular complications 61 left ventricular dysfunction 61 renal dysfunction 61 Nesiritide 61 PSVT 61 ischemic complications 61 ARCOXIA 61 endometrial carcinoma 61 postoperative mortality 61 ischemic cardiovascular 61 valvular disease 61 everolimus eluting stents 61 cerebrovascular accident 61 events MACE 61 antiplatelet agent 61 stroke myocardial infarction 61 ventricular fibrillation VF 61 XIENCE V vs. 61 hypercalcemia 61 sustained ventricular tachycardia 61 torsade de pointes 61 tolvaptan 61 myocardial ischemia 61 paclitaxel eluting stents 61 atrial fibrillation AF 61 nephrotoxicity 61 elevated LDL cholesterol 61 hyperkalemia 61 ketoacidosis hyperosmolar coma 61 PRADAXA 60 hepatocellular carcinoma liver 60 MULTAQ 60 atrioventricular block 60 death reinfarction 60 serum calcium levels 60 NYHA Class III 60 atherothrombotic 60 torsades de pointes 60 paroxysmal AF 60 subclinical hypothyroidism 60 endarterectomy 60 NATRECOR R 60 left ventricular hypertrophy 60 ST elevation myocardial 60 endometrial hyperplasia 60 draining enterocutaneous 60 symptomatic intracranial hemorrhage 60 ACE inhibitor ramipril 60 candesartan 60 XIENCE V demonstrated 60 urgent coronary revascularization 60 vertebral fracture 60 nonfasting triglycerides 60 postoperative atrial fibrillation 60 noncardiovascular 60 chronic thromboembolic pulmonary 60 acute coronary syndrome 60 carotid IMT 60 tirofiban 60 CMV infection 60 cirrhosis liver cancer 60 coronary atherosclerosis 60 ximelagatran 60 PAOD 60 invasive aspergillosis 60 microalbuminuria 60 perioperative morbidity 60 systolic hypertension 60 morbidity mortality 60 pexelizumab 60 PLX STROKE targeting 60 stable angina 60 recurrent glioblastoma multiforme 60 Severe hypoglycemia 60 colorectal adenoma 60 microvascular disease 60 NSTEMI 60 infarction STEMI 60 x ULN 60 hyperglycaemia 60 acute STEMI 60 IIIa inhibitor 60 Ranolazine 60 anticoagulants blood thinners 60 target vessel revascularization 60 renal insufficiency 60 landmark ATHENA trial 60 virologic failure 60 stent thrombosis 60 serum uric acid 60 revascularisation 60 secondary efficacy endpoint 60 prolonged QT interval 60 salmeterol fluticasone 60 revascularizations 60 LVSD 60 angiographic outcomes 60 enoximone 60 olmesartan 59 angiographic restenosis 59 recurrent atrial fibrillation 59 neurologic progression 59 perindopril 59 leukemia AML 59 periprocedural MI 59 onset atrial fibrillation 59 MS relapses 59 post thrombotic syndrome 59 contrast induced nephropathy 59 systolic dysfunction 59 androgen deprivation 59 VIIBRYD 59 revascularization procedures 59 noncardiovascular mortality 59 Adjuvant chemotherapy 59 ticagrelor 59 cytopenias 59 EXJADE 59 invasive candidiasis 59 intracerebral hemorrhage 59 TNF antagonist 59 paroxysmal atrial fibrillation 59 ketoacidosis coma 59 cardiovascular disease CVD 59 cerebral infarction 59 patients undergoing percutaneous 59 CDI recurrence 59 KIF6 carriers 59 eptifibatide 59 nonfatal cardiovascular 59 fatal arrhythmic 59 variceal 59 prospectively defined 59 cerebral vasospasm 59 serum phosphorus 59 persistent pulmonary hypertension 59 atherosclerotic disease 59 COPD exacerbations 59 DULERA 59 cerebral vascular disease 59 extrapyramidal symptoms 59 mm Stent 59 embolic stroke 59 QTc prolongation 59 ventricular dysfunction 59 symptomatic intracranial 59 cilostazol 59 TEAEs 59 Folfox 59 Diabetic nephropathy 59 postoperative morbidity 59 PEGINTRON TM 59 VTE 59 CYPHER Stent 59 pericardial effusion 59 GP IIb IIIa inhibitors 59 atheroma volume 59 riociguat 59 muraglitazar 59 gout flares 58 prostate cancer CaP 58 hypercalcaemia 58 haemorrhagic stroke 58 Torsades de Pointes 58 prednisone prednisolone 58 neurodevelopmental impairment 58 mL/min/#.# m 2 58 acute coronary 58 mcg QD 58 platelet reactivity 58 locoregional recurrence 58 inhospital 58 coagulation abnormalities 58 unfractionated heparin 58 hypoxemia 58 coronary revascularization procedures 58 clopidogrel Plavix 58 evaluating tivozanib 58 proximal DVT 58 oxycodone CR 58 baseline HbA1c 58 untreated OSA 58 cobiprostone 58 candesartan cilexetil 58 venous thromboembolisms 58 coronary stenosis 58 pulmonary exacerbations 58 discontinuations due 58 HMG CoA reductase inhibitors 58 ventricular remodeling 58 irbesartan 58 ventricular arrhythmia 58 coronary revascularisation 58 Renal dysfunction 58 ACTEMRA TM 58 severe neutropenia 58 serum urate 58 intima media thickness 58 autoantibody levels 58 TAXUS Liberte Long 58 reblockage 58 1mg dose 58 nonvertebral fracture 58 MADIT II 58 cardiotoxicity 58 ruboxistaurin 58 Thal Dex 58 perioperative complications 58 Hb A1C 58 ramipril 58 severe hypoglycemic 58 severe hypoglycemia 58 debilitating complication 58 spontaneous preterm delivery 58 thiazide diuretic 58 annualized relapse 58 benazepril 58 nonvertebral fractures 58 Stent thrombosis 58 CYPHER ® Stent 58 HbA1c levels 58 Hazard Ratio 58 severe asthma exacerbations 58 fatal pulmonary embolism 58 fluvastatin 58 vertebral fractures 58 levosimendan 58 tachyarrhythmias 58 carotid intima media 58 rFVIIa 58 atherogenic dyslipidemia 58 octreotide LAR 58 DU #b 58 posaconazole 58 Subarachnoid hemorrhage 58 UA NSTEMI 58 thrombotic complications 58 systemic corticosteroid 58 T2DM 58 severe oral mucositis 58 heparin induced thrombocytopenia 58 neointimal hyperplasia 58 thrombolytic agents 58 PRADAXA #mg 58 ventricular tachycardia VT 58 Hypotension 58 acute ischemic 58 sirolimus stent 58 BENICAR HCT 58 cardioembolic stroke 58 arterial calcification 58 fluid overload 58 unfractionated heparin UFH 58 venous blood clots 58 angina chest 58 vascular inflammation 58 serum aminotransferase levels 58 carotid atherosclerosis 58 valsartan 58 serum creatinine levels 58 plus gemcitabine 58 neutropenia dehydration dyspnea 58 adenoma recurrence 58 ExTRACT TIMI 58 KRAS mutations occur 58 angiotensin converting enzyme inhibitors 58 confidence interval #.#-#.# 58 Octreolin 58 Uncontrolled hypertension 58 acute decompensation 58 mycophenolate mofetil 58 peginterferon alfa 2a 58 macroalbuminuria 58 proliferative diabetic retinopathy 58 undergoing coronary artery 58 metastatic castration resistant 58 sotalol 58 CRT Ds 58 dacarbazine 58 neurologic complications 58 NYHA class 58 Coronary artery disease 58 antithrombotic therapies 58 QT prolongation 58 undergoing coronary angiography 58 homozygous familial hypercholesterolemia 58 Multaq R 57 teriflunomide 57 TAXUS Stent 57 antihypertensive therapy 57 venous thromboembolic disease 57 R0 resection 57 darapladib 57 induce orthostatic hypotension 57 occlusive disease 57 prophylactic therapy 57 FOLFIRI 57 thyrotropin levels 57 cabazitaxel 57 stenoses 57 angina myocardial infarction 57 acute myocardial infarctions 57 aspirin heparin 57 COPD exacerbation 57 sinus rhythm 57 neutrophil counts 57 idraparinux 57 biologic DMARD 57 uncontrolled asthma 57 TAXUS stent 57 metastatic malignant 57 stroke transient ischemic 57 fosamprenavir 57 Primary endpoints 57 CR nPR 57 infusional 5-FU/LV 57 intraventricular hemorrhage 57 bivalirudin 57 severe aortic stenosis 57 cryptogenic stroke 57 Heart Failure Trial 57 sUA 57 nadolol 57 serum uric acid sUA 57 elotuzumab 57 pyrexia mucositis sepsis febrile 57 CNS systemic embolism 57 postoperative bleeding 57 Pulmonary embolism 57 adjunctive placebo 57 primary generalized tonic 57 revascularization procedure 57 catheter angiography 57 nonfatal heart 57 vandetanib 57 intracranial bleeding 57 TAXUS Liberté stent 57 Procoralan 57 advanced adenoma 57 SREs 57 interstitial pneumonitis 57 statin therapy 57 H. pylori eradication 57 ACEI ARB 57 lumiracoxib 57 VELCADE melphalan 57 MICARDIS ® 57 advanced adenomas 57 A1c levels 57 bone marrow reticulin 57 GP IIb IIIa inhibitor 57 acute coronary syndromes 57 necrotizing pancreatitis 57 dalteparin 57 Atrial fibrillation AF 57 asymptomatic carotid stenosis 57 cirrhotic patients 57 CTEPH 57 ST Segment Elevation 57 unstable angina 57 unstable angina UA 57 baseline serum creatinine 57 grade cervical intraepithelial 57 subtrochanteric 57 velafermin 57 elevated IOP 57 symptomatic aortic stenosis 57 TAVR 57 spinal cord compression 57 adrenal insufficiency 57 carotid artery blockage 57 nonischemic 57 left ventricular systolic 57 CYPHER ® 57 failure ADHF 57 Operative mortality 57 stable angina pectoris 57 malignant neoplasms 57 venous thromboembolism 57 CK MB 57 metabolic acidosis 57 symptomatic pulmonary embolism 57 variant angina 57 schizophrenia CIAS 57 Idiopathic pulmonary fibrosis 57 fondaparinux 57 hepatotoxicity 57 RE LY ® 57 target lesion revascularization 57 apo B 57 troponin T 57 MIs 57 serum triglycerides 57 primary hypercholesterolemia 57 fibrinolysis 57 catheter occlusion 57 thrombocytopenic 57 postoperative pulmonary 57 complete cytogenetic response 57 Serious adverse reactions 57 corticosteroid dose 57 cardiac contractility 57 CIMZIA ™ 57 dysrhythmias 57 AA Amyloidosis 57 alteplase 57 chlorambucil 57 metformin sulfonylurea 57 peripheral sensory neuropathy 57 Infusion Reactions Severe 57 Major Adverse Cardiac 57 del 5q MDS 57 histologically confirmed 57 reintervention 57 segment elevation myocardial 57 oral FTY# 57 endophthalmitis 57 Unstable angina 57 variceal bleeding 57 liver decompensation 57 myocardial infarctions MIs 57 clinically meaningful reductions 57 vasospasm 57 VTEs 57 salmeterol fluticasone propionate 57 Statin therapy 57 hemodynamic instability 57 serum phosphate 57 PSA nadir 57 serum phosphate levels 57 nonalcoholic steatohepatitis 57 venous thrombosis 57 perioperatively 57 renal scarring 57 angiotensin converting enzyme inhibitor 57 rolofylline 57 coronary intervention 57 acromegalic patients 57 warfarin therapy 57 anticoagulation therapy 57 myocardial reperfusion 57 mixed hyperlipidemia 57 HbA1C levels 57 ribavirin USP 57 doxorubicin docetaxel 57 Abbott Trilipix 57 Chronic hepatitis C 57 macrovascular disease 57 FASLODEX 57 clinically localized prostate 57 stent thrombosis blood clots 57 peripheral arterial occlusive disease 57 recurrent coronary 57 gemcitabine Gemzar 57 arterial revascularization 57 hematologic toxicity 57 pulmonary embolus 57 Unstable Angina 56 dose atorvastatin 56 hepatic impairment 56 HIV HCV coinfected 56 NPH insulin 56 bradycardia 56 silent ischemia 56 postoperative complication 56 intravenous bisphosphonates 56 serum triglyceride levels 56 Radical prostatectomy 56 overt hepatic encephalopathy HE 56 enoxaparin 56 variceal hemorrhage 56 hormone receptor negative 56 β blocker 56 Sudden Cardiac Death 56 malignant neoplasm 56 detrusor overactivity 56 gastrointestinal perforation 56 Postoperative complications 56 fraction LVEF 56 refractory angina 56 gadolinium enhancing lesions 56 lopinavir r arm 56 deep venous thromboses 56 PRIMO CABG2 56 hypoglycemic events 56 invasive ductal 56 cerebrovascular accidents 56 prasugrel uh prevented 56 stent implantation 56 sustained virological response 56 deferiprone 56 ventricular tachyarrhythmias 56 dose clopidogrel 56 ULORIC 56 administered erythropoiesis stimulating 56 MGd 56 ventricular arrhythmias 56 hypercholesterolaemia 56 HAM D# scores 56 5-FU/LV 56 coronary artery disease 56 bosentan 56 carotid endarterectomy CEA 56 receiving INTRON 56 % CI #.#-#.# [007] 56 renal toxicity 56 cardiac resynchronization 56 varices 56 Non Alcoholic Steatohepatitis 56 oral anticoagulant 56 dosing cohort 56 metastatic GIST 56 venous thromboembolism VTE 56 MIST II 56 BYSTOLIC 56 LV hypertrophy 56 HBeAg seroconversion 56 INCB# [003] 56 Hemorrhagic stroke 56 biochemical recurrence 56 nab paclitaxel 56 TORISEL 56 antiplatelet drugs 56 zonisamide SR 56 lomitapide 56 eritoran 56 NSTE ACS 56 mcg BID 56 tHcy 56 severe sepsis 56 curative resection 56 FROVA 56 antiarrhythmic drugs 56 atrial fibrillation atrial flutter 56 irregular quivering 56 cardiogenic pulmonary edema 56 plus dexamethasone 56 concomitant medications 56 ACTOplus met 56 aplastic anemia AA 56 Primary Hypercholesterolemia 56 Restenosis 56 hepatorenal syndrome 56 xanthine oxidase inhibitor 56 ribavirin therapy 56 chronic idiopathic thrombocytopenic purpura 56 reoperations 56 gangrene amputation 56 symptomatic atrial fibrillation 56 Vidaza ® 56 clazosentan 56 atrial arrhythmias 56 ischemic stroke 56 nocturnal hypoglycemia 56 thromboses 56 coadministration 56 plasma uric acid 56 FOLFOX6 chemotherapy regimen 56 hepatic cirrhosis 56 CCyR 56 Lactic acidosis 56 metachronous 56 RoACTEMRA 56 pretest probability 56 myocardial ischaemia 56 FOLFOX4 56 anti arrhythmic drug 56 Myocardial Infarction Study 56 mRCC 56 angiotensin receptor blockers ARBs 56 renal impairment 56 external genital lesions 56 angina pectoris 56 Ishak fibrosis score 56 intracerebral haemorrhage 56 Col. Souza Filho 56 drotrecogin alfa activated 56 reperfusion injury 56 canakinumab 56 systemic corticosteroids 56 relapsed MM 56 noncardiac 56 metastatic renal cell carcinoma 56 cardiovascular disease hypertension 56 ticlopidine 56 aortic valve stenosis 56 candidemia 56 NIHSS score 56 luminal diameter 56 Peripheral arterial disease 56 anastomotic leak 56 dysglycemia 56 prostate TURP 56 DES implantation 56 generalized edema 56 occlusion CRVO 56 aneurysm rupture 56 opioid induced bowel dysfunction 56 atherosclerotic progression 56 fibrosis scarring 56 desvenlafaxine succinate 56 Left ventricular hypertrophy 56 maintaining fistula 56 asymptomatic PAD 56 biochemical relapse 56 PASI scores 56 alemtuzumab treated 56 bypass graft CABG surgery 56 systemic immunosuppressive drugs 56 PREZISTA r arm 56 beclomethasone dipropionate 56 acute myocardial infarction 56 Coronary heart 56 uncoated stent 56 Decompensated Heart Failure 56 fractional shortening 56 ABCB1 56 dyslipidaemia 56 severe renal impairment 56 placebo controlled clinical 56 plasma triglycerides 56 laboratory abnormalities 56 retinal vein occlusion 56 unresectable HCC 56 medullary thyroid cancer 56 FluCAM arm 56 achieved ACR# 56 recurrent wheezing 56 CRBSI 56 intravenous diuretics 56 aspirin clopidogrel 56 lispro 56 thrombolytic therapy 56 hippocampal atrophy 56 atrophic gastritis 56 circulatory diseases 56 inhibitor RG# 56 certolizumab 56 perinatal morbidity 56 carboplatin paclitaxel 56 refractory AML 56 Acute Coronary Syndrome 56 PREZISTA r 56 neovascular AMD 56 clodronate 56 CK # plasma concentrations 56 Critical limb ischemia 56 salmeterol inhalation powder 56 abciximab 56 nesiritide 56 multivariate adjustment 56 dyslipidemia hypertension diabetes 56 onset diabetes mellitus 56 Natalizumab 56 HbA 1c 56 tenecteplase 56 progressive dyspnea 56 resynchronization therapy 56 #mg/dL [001] 56 Coronary artery calcification 56 #mmHg [001] 56 creatinine clearance 56 uncontrolled hypertension 56 apnea hypopnea index 56 PRIMO CABG 56 TRAIL R1 56 MYDICAR 56 CsA 56 paralysis coma 56 reduce serum phosphate 56 abacavir lamivudine 55 pulmonary thromboembolism 55 Cimzia TM 55 Lupuzor ™ 55 thromboprophylaxis 55 STEMI patients 55 rosuvastatin 55 bronchospasm 55 diabetic nephropathy 55 AZOR 55 ALND 55 postoperative delirium 55 rosuvastatin Crestor 55 proteinuria 55 graft occlusion 55 Stomach stapling 55 liver metastasis 55 leukopenia 55 thromboembolic disorders 55 CHD coronary 55 intraoperative complications 55 Exacerbations 55 rimonabant #mg 55 CYT# potent vascular disrupting 55 Thrombolysis 55 intracranial hemorrhage ICH 55 TAXUS Express Atom Stent 55 Rasilez Tekturna 55 mitral regurgitation MR 55 aneurysmal subarachnoid hemorrhage 55 cinacalcet 55 coma convulsions 55 Dronedarone 55 hemodialysis patients 55 daclizumab 55 graft dysfunction 55 antiplatelet medications 55 platelet inhibition 55 mg BID dose 55 hsCRP levels 55 atherothrombosis 55 bacteremia 55 ACUITY trial 55 VADT 55 Colorectal cancers 55 pioglitazone 55 neurocognitive deficits 55 virological failure 55 Chronic Heart Failure 55 CRVO 55 primidone 55 tumor recurrence 55 sulphonylurea 55 D dimer 55 seropositive patients 55 chronic periodontitis 55 lipid lowering therapy 55 asthma exacerbations 55 NEVO ™ 55 febrile neutropenia 55 noncardiac surgery 55 rhythm disturbances 55 Tavocept 55 cyclophosphamide methotrexate 55 ARB telmisartan 55 symptomatic hyponatremia 55 unresectable tumors 55 aldosterone antagonist 55 hypokalemia 55 serum urate levels 55 CIMZIA TM certolizumab pegol 55 ancrod 55 ® lenalidomide 55 gastrointestinal bleeds 55 Acute Myocardial Infarction 55 Diabetic Macular Edema 55 Pulmonary hypertension 55 metformin accumulation 55 Abciximab 55 treatment emergent adverse 55 endoscopic remission 55 recurrent genital herpes 55 interferon beta therapy 55 artery stenosis 55 PEGylated interferon beta 1a 55 adenomatous polyps 55 skeletal metastases 55 segment binary restenosis 55 stent thromboses 55 chronic HCV infection 55 elevated uric acid 55 TNF Tumor Necrosis Factor 55 cytoreductive surgery 55 PROMACTA 55 lipid lowering drugs 55 Carotid Revascularization Endarterectomy vs. 55 tachyarrhythmia 55 ertapenem 55 goserelin 55 carotid bruit 55 macular edema secondary 55 fainting lightheadedness 55 Candesartan 55 natriuresis 55 Aortic stenosis 55 smoldering myeloma 55 hepatocellular 55 nonadherence 55 cardiac toxicity 55 phase IIb study 55 bronchopulmonary dysplasia 55 angiotensin receptor blocker ARB 55 Vascular dementia 55 antiplatelet therapy 55 PFO closure 55 lipoprotein Lp 55 infective endocarditis 55 flutamide 55 HES CEL 55 oral allopurinol 55 lowering blood glucose 55 #mg BID [001] 55 vaso occlusive crisis 55 ocrelizumab 55 CMV disease 55 lipid lowering agents 55 coronary stenoses 55 pneumonectomy 55 colesevelam HCl 55 Menopausal hormone therapy 55 malperfusion 55 TAXUS Liberte stent 55 SHPT 55 HDL LDL ratio 55 SLNB 55 hyperphosphatemia 55 cerebrovascular disease 55 NYHA functional class 55 ELACYT 55 coinfected patients 55 XELOX 55 radiochemotherapy 55 aldosterone antagonists 55 Lupus nephritis 55 complement inhibitor eculizumab 55 tapentadol ER 55 diastolic heart 55 obstructive coronary artery 55 QTc 55 hypotension 55 liver transplant recipients 55 hypertension congestive heart 55 refractory NSCLC 55 Sudden cardiac death 55 corticosteroid therapy 55 Gemzar ® 55 glycosylated hemoglobin HbA1c 55 hemoglobin A1c HbA1c 55 coronary heart 55 Prehypertension 55 pain palliation 55 anticoagulant warfarin 55 fibrinolytic therapy 55 chemoradiotherapy 55 Thrombin Receptor Antagonist 55 IOP lowering 55 ICD shocks 55 either acutely decompensated 55 VAPRISOL 55 EURIDIS 55 revascularization 55 haloperidol Haldol 55 MEND CABG 55 hypophosphatemia 55 Scale EDSS score 55 Ivabradine 55 reinterventions 55 cholesterol LDL C 55 ICD implantation 55 Subgroup analysis 55 pulmonary resection 55 paroxetine Paxil 55 Tarceva TM 55 Ischemic stroke 55 LEXIVA r 55 bone metastasis 55 p = NS 55 intensive statin therapy 55 fatal hemorrhagic 55 AVONEX ® 55 pioglitazone HCl 55 endometriosis ovarian cysts 55 enalapril 55 Mylotarg 55 glomerular filtration 55 TAXUS 55 cytogenetic response 55 spinal metastases 55 virologic response 55 C1 INH deficiency 55 syncopal 55 multivessel disease 55 ejection fractions 55 AAT deficiency 55 severe rotavirus gastroenteritis 55 fluticasone salmeterol 55 hypoglycaemic episodes 55 grade glioma 55 opioid overdose 55 Myocardial Infarction 55 de novo lesions 55 hepatic failure 55 #.#mg/dL 55 Amrubicin